GEN-MKT-18-7897-A
May 6, 2019 | Blogs, Software, Technology | 0 comments
You’ve bought your mass spectrometer. You’ve installed all your hardware. You’ve got your operating software set up. You’ve mastered your software workflow modules to optimize quantitative and qualitative data processing. That’s it, right?
Even though your system is running smoothly, you’ll need to stay current with new software features to make your job easier, expand your system’s capabilities, and grow your lab´s productivity. The best way to do this is with a Software Support Contract.
A support plan gives you access to new releases and bug fixes for either your instrument software that is provided with the instrument, or non-instrument software (application vertical software), or both.
We publish software updates several times a year as new features and capabilities become available. Recently, new versions of SCIEX OS Software were released. Application vertical software can also be affected by hardware and third-party software updates. Remaining current with all of your software will help minimize potential instrument downtime.
Our software support contracts portfolio comes with a variety of features and benefits matching your unique needs and requirements.
Although we all expect the solutions we buy and install to work easily and consistently, technology – especially complex systems made up of lots of components sitting on a network – may require vendor support to get up and running. There are also times when you may just need some advice on how best to approach a hardware change, software update or day-to-day user questions. Having a support agreement already in place can save you time, money, and hassle.
Compare the ease of picking up the phone to connect to a friendly support technician, with no need to consider cost or process, with the alternative:
SCIEX Software Support Plans also let you jump the queue to get priority support before users who don’t have one. And, they’re renewed on an annual basis, so your coverage never needs to lapse.
Want to know more, sign up for a plan that matches your lab’s goals or check the status of your current agreement?Contact Us >
In biopharmaceutical development, sequence variants (SV) are considered an inherent risk of producing complex proteins in living systems. Sequence variants are unintended changes to the amino acid sequence of a biotherapeutic and can be caused by errors in transcription or translation in the host cell, or cell culture and process conditions. Detailed analysis of SVs is important in process and product development to ensure the drug’s safety and efficacy. Even low‑level sequence variants can have significant implications for product quality, safety, and efficacy, making their accurate detection and characterization a critical requirement across development, process optimization, and regulatory submission.
CE‑SDS remains a cornerstone assay for characterizing fragmentation, aggregation, and product‑related impurities in therapeutic proteins. UV detection has been the long‑standing standard. However, it frequently struggles with baseline noise, limited sensitivity for minor fragments, and subjective integration.
At SCIEX, innovation doesn’t stop at instruments; it extends to how you interact with your LC-MS/MS or CE systems every day. That’s why we’re excited to introduce the SCIEX Now spring 2026 improvements: a set of meaningful enhancements shaped directly by your feedback.
Posted by
You must be logged in to post a comment.
Share this post with your network